196 related articles for article (PubMed ID: 33626532)
1. Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients.
Casadei-Gardini A; Filippi R; Rimini M; Rapposelli IG; Fornaro L; Silvestris N; Aldrighetti L; Aimar G; Rovesti G; Bartolini G; Vivaldi C; Brunetti O; Sperti E; La Face R; Ratti F; Andrikou K; Valgiusti M; Bernardini L; Argentiero A; Fenocchio E; Frassineti GL; Cesario S; Giovannelli F; Quarà V; Leone F; Cascinu S
Oncology; 2021; 99(5):292-299. PubMed ID: 33626532
[TBL] [Abstract][Full Text] [Related]
2. Metformin does not improve survival of cholangiocarcinoma patients with diabetes.
Yang Z; Zhang X; Roberts RO; Roberts LR; Chaiteerakij R
Hepatology; 2016 Feb; 63(2):667-8. PubMed ID: 25833233
[No Abstract] [Full Text] [Related]
3. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Metformin Use for Cholangiocarcinoma.
Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Pholsripradit P; Eksanti T; Phatisena T; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(18):8079-83. PubMed ID: 26745042
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
6. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
8. An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.
Kato A; Naitoh I; Miyabe K; Hayashi K; Yoshida M; Hori Y; Natsume M; Jinno N; Asano G; Kato H; Kuno T; Takahashi S; Kataoka H
Dig Dis Sci; 2018 Dec; 63(12):3376-3381. PubMed ID: 30206756
[TBL] [Abstract][Full Text] [Related]
9. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
Si A; Li J; Yang Z; Xia Y; Yang T; Lei Z; Cheng Z; Pawlik TM; Lau WY; Shen F
Ann Surg Oncol; 2019 Jun; 26(6):1841-1850. PubMed ID: 30843164
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
11. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
12. Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients.
Akahoshi K; Ban D; Kuboki R; Oba A; Ono H; Mitsunori Y; Kudo A; Tanaka S; Tanabe M
J Gastroenterol Hepatol; 2019 Jun; 34(6):1108-1115. PubMed ID: 30242888
[TBL] [Abstract][Full Text] [Related]
13. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Golan T; Raitses-Gurevich M; Kelley RK; Bocobo AG; Borgida A; Shroff RT; Holter S; Gallinger S; Ahn DH; Aderka D; Apurva J; Bekaii-Saab T; Friedman E; Javle M
Oncologist; 2017 Jul; 22(7):804-810. PubMed ID: 28487467
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting survival time of cholangiocarcinoma patients: a prospective study in Northeast Thailand.
Woradet S; Promthet S; Songserm N; Parkin DM
Asian Pac J Cancer Prev; 2013; 14(3):1623-7. PubMed ID: 23679246
[TBL] [Abstract][Full Text] [Related]
15. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
Sur MD; In H; Sharpe SM; Baker MS; Weichselbaum RR; Talamonti MS; Posner MC
Ann Surg Oncol; 2015 Jul; 22(7):2209-17. PubMed ID: 25476031
[TBL] [Abstract][Full Text] [Related]
16. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
J Surg Oncol; 2020 Nov; 122(6):1094-1105. PubMed ID: 32634266
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.
Uhlig J; Sellers CM; Cha C; Khan SA; Lacy J; Stein SM; Kim HS
Ann Surg Oncol; 2019 Jul; 26(7):1993-2000. PubMed ID: 30693451
[TBL] [Abstract][Full Text] [Related]
18. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
20. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]